Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel LY900014 Formulation
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2015
At a glance
- Drugs Insulin lispro (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 15 Oct 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 01 Oct 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 08 Sep 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Sep 2015 as per ClinicalTrials.gov record.